YUAN Yan-xia, LIN Lin, FENG Su-ying, ZHOU Wu-qing, WU Jian-bing. Serum levels of several chemokines in patients with bullous pemphigoid[J].Chinese Journal of Dermatology, 2007, 40(9): 558-559.
[1] Czech W,Schaller J,Schopf E,et al.Granulocyte activation in bullous diseases:release of granular proteins in bullous pemphigoid and pemphigus vulgaris.J Am Acad Dermatol,1993,29:210-215. [2] Sallusto F,Lanzavecchia A,Mackay CR.Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses.Immunol Today,1998,19:568-574. [3] Amerio P,Frezzolini A,Feliciani C,et al.Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases:therapeutical implications.Curr Drug Targets Inflamm Allergy,2003,2:81-94. [4] Frezzolini A,Teofoli P,Cianchini G,et al.Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.Eur J Dermatol,2002,12:27-31. [5] Gounni Abdelilah S,Wellemans V,et al.Increased expression of Th2-associated chemokines in bullous pemphigoid disease.Role of eosinophils in the production and release of these chemokines.Clin Immunol,2006,2:220-231.